The Role of Genetic Factors in the Development of Atopic Dermatitis in the Kazakh Population
NCT05090631 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2023-03-14
Summary
This is a GWAS study that aims to identify possible candidate genes associate to atopic dermatitisby exploring single nucleotide polymorphism (SNP) in a group of atopic dermatitis, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with atopic dermatitis
Conditions
Interventions
- GENETIC
-
DNA analysis
GWAS
Sponsors & Collaborators
-
Asfendiyarov Kazakh National Medical University
lead OTHER
Principal Investigators
-
Gulya Sarybaeva, PhD · Asfendiyarov Kazakh National Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-23
- Primary Completion
- 2023-01-20
- Completion
- 2023-01-20
Countries
- Kazakhstan
Study Locations
More Related Trials
-
Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis
NCT04753034 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis
NCT06931990 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Study Evaluating the Safety and Efficacy of QGE031 in Atopic Dermatitis Patients
NCT01552629 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels
NCT00616096 ·Status: COMPLETED ·Phase: NA
-
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
NCT07223697 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis
NCT03568071 ·Status: TERMINATED ·Phase: PHASE2
-
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
NCT05454462 ·Status: COMPLETED ·Phase: PHASE1
-
Microbiome in Atopic Dermatitis Under Systemic Therapy
NCT05099315 ·Status: RECRUITING
-
A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis
NCT03689829 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients
NCT02426359 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine
NCT04686955 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
NCT06945458 ·Status: COMPLETED ·Phase: PHASE1
-
Distribution of Tacrolimus in Skin, Atopic Dermatitis
NCT00534508 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
NCT06058000 ·Status: COMPLETED ·Phase: PHASE2
-
Herbal Ointment in Treating Atopic Dermatitis Topically
NCT06850311 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study of the Skin Microbiome and the Potential of a Topical Probiotic Cream for Atopic Dermatitis
NCT04771910 ·Status: UNKNOWN ·Phase: NA
-
A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis
NCT06116565 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Skin Barrier Abnormalities and Oxidative Stress Response
NCT04606615 ·Status: UNKNOWN
-
Long-term Safety and Efficacy of Lebrikizumab in Adult and Adolescent Participant With Moderate-to-Severe Atopic Dermatitis
NCT05916365 ·Status: COMPLETED ·Phase: PHASE3
-
China Atopic Dermatitis Registry Study
NCT05023668 ·Status: UNKNOWN
-
Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.
NCT06447506 ·Status: TERMINATED ·Phase: PHASE2
-
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
NCT07003425 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
NCT05807113 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
NCT04717310 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis
NCT05265923 ·Status: COMPLETED ·Phase: PHASE3